[{"address1": "1111 Lincoln Road", "address2": "Suite 500", "city": "Miami Beach", "state": "FL", "zip": "33139", "country": "United States", "phone": "786 977 3380", "website": "https://www.pasithea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lawrence  Steinman BA, M.D., Ph.D.", "age": 77, "title": "Co-Founder, MD & Executive Chairman", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 250000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tiago Reis Marques M.D., Ph.D.", "age": 48, "title": "CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 450000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel H. Schneiderman", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 330000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9087, "open": 0.89, "dayLow": 0.8721, "dayHigh": 0.9134, "regularMarketPreviousClose": 0.9087, "regularMarketOpen": 0.89, "regularMarketDayLow": 0.8721, "regularMarketDayHigh": 0.9134, "payoutRatio": 0.0, "beta": 0.222, "forwardPE": -1.3235294, "volume": 84565, "regularMarketVolume": 84565, "averageVolume": 7383413, "averageVolume10days": 162850, "averageDailyVolume10Day": 162850, "bid": 0.8639, "ask": 1.15, "bidSize": 1, "askSize": 2, "marketCap": 20781956, "fiftyTwoWeekLow": 0.281, "fiftyTwoWeekHigh": 3.85, "allTimeHigh": 170.0, "allTimeLow": 0.281, "fiftyDayAverage": 0.9687, "twoHundredDayAverage": 0.896045, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2576266, "profitMargins": 0.0, "floatShares": 5969674, "sharesOutstanding": 23091062, "sharesShort": 559624, "sharesShortPriorMonth": 3857828, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0242, "heldPercentInsiders": 0.01613, "heldPercentInstitutions": 0.22193001, "shortRatio": 0.46, "shortPercentOfFloat": 0.024600001, "impliedSharesOutstanding": 23091062, "bookValue": 1.64, "priceToBook": 0.5487805, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13494476, "trailingEps": -4.43, "forwardEps": -0.68, "lastSplitFactor": "1:20", "lastSplitDate": 1704153600, "enterpriseToEbitda": -0.195, "52WeekChange": -0.6392857, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 0.9, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 4122953, "totalCashPerShare": 0.554, "ebitda": -13194081, "totalDebt": 0, "quickRatio": 2.994, "currentRatio": 4.015, "returnOnAssets": -0.53696, "returnOnEquity": -0.89902997, "freeCashflow": -7940062, "operatingCashflow": -12257704, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KTTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekChangePercent": -63.92857, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755374400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.43, "epsForward": -0.68, "epsCurrentYear": -1.5, "priceEpsCurrentYear": -0.59999996, "shortName": "Pasithea Therapeutics Corp.", "longName": "Pasithea Therapeutics Corp.", "corporateActions": [], "postMarketTime": 1769214005, "regularMarketTime": 1769202001, "exchange": "NCM", "messageBoardId": "finmb_702706441", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.957413, "regularMarketPrice": 0.9, "fiftyDayAverageChange": -0.068700016, "fiftyDayAverageChangePercent": -0.070919804, "twoHundredDayAverageChange": 0.003954947, "twoHundredDayAverageChangePercent": 0.0044137817, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": -3.0111074, "postMarketPrice": 0.8729, "postMarketChange": -0.027099967, "regularMarketChange": -0.00870001, "regularMarketDayRange": "0.8721 - 0.9134", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 7383413, "fiftyTwoWeekLowChange": 0.61899996, "fiftyTwoWeekLowChangePercent": 2.202847, "fiftyTwoWeekRange": "0.281 - 3.85", "fiftyTwoWeekHighChange": -2.9499998, "fiftyTwoWeekHighChangePercent": -0.76623374, "marketState": "CLOSED", "displayName": "Pasithea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]